JP2022513159A5 - - Google Patents

Info

Publication number
JP2022513159A5
JP2022513159A5 JP2021530978A JP2021530978A JP2022513159A5 JP 2022513159 A5 JP2022513159 A5 JP 2022513159A5 JP 2021530978 A JP2021530978 A JP 2021530978A JP 2021530978 A JP2021530978 A JP 2021530978A JP 2022513159 A5 JP2022513159 A5 JP 2022513159A5
Authority
JP
Japan
Prior art keywords
rna
sequence
target rna
polypeptide
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021530978A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513159A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063798 external-priority patent/WO2020113135A1/en
Publication of JP2022513159A publication Critical patent/JP2022513159A/ja
Publication of JP2022513159A5 publication Critical patent/JP2022513159A5/ja
Pending legal-status Critical Current

Links

JP2021530978A 2018-11-29 2019-11-27 Rnaを調節する方法 Pending JP2022513159A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862772907P 2018-11-29 2018-11-29
US62/772,907 2018-11-29
US201862778361P 2018-12-12 2018-12-12
US62/778,361 2018-12-12
US201862780442P 2018-12-17 2018-12-17
US62/780,442 2018-12-17
PCT/US2019/063798 WO2020113135A1 (en) 2018-11-29 2019-11-27 Methods of modulating rna

Publications (2)

Publication Number Publication Date
JP2022513159A JP2022513159A (ja) 2022-02-07
JP2022513159A5 true JP2022513159A5 (cg-RX-API-DMAC10.html) 2022-12-08

Family

ID=68966069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021530978A Pending JP2022513159A (ja) 2018-11-29 2019-11-27 Rnaを調節する方法

Country Status (5)

Country Link
US (1) US20220024999A1 (cg-RX-API-DMAC10.html)
EP (1) EP3887516A1 (cg-RX-API-DMAC10.html)
JP (1) JP2022513159A (cg-RX-API-DMAC10.html)
CN (1) CN113454216A (cg-RX-API-DMAC10.html)
WO (1) WO2020113135A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018049075A1 (en) 2016-09-07 2018-03-15 Flagship Pioneering, Inc. Methods and compositions for modulating gene expression
US11827880B2 (en) 2019-12-02 2023-11-28 Shape Therapeutics Inc. Therapeutic editing

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4426330A (en) 1981-07-20 1984-01-17 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4534899A (en) 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
GB8824593D0 (en) 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5356633A (en) 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5665710A (en) 1990-04-30 1997-09-09 Georgetown University Method of making liposomal oligodeoxynucleotide compositions
JP3220180B2 (ja) 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
JP3351476B2 (ja) 1993-01-22 2002-11-25 三菱化学株式会社 リン脂質誘導体及びそれを含有するリポソーム
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
CA2137297C (en) 1993-12-06 2000-04-18 Tsuyoshi Miyazaki Reactive vesicle and functional substance-fixed vesicle
US5543152A (en) 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5820873A (en) 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
US5756122A (en) 1995-06-07 1998-05-26 Georgetown University Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
US5858397A (en) 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
ATE237312T1 (de) 1998-07-20 2003-05-15 Protiva Biotherapeutics Inc In liposomen verkapselte nukleinsäurekomplexe
US9580714B2 (en) * 2010-11-24 2017-02-28 The University Of Western Australia Peptides for the specific binding of RNA targets
US9133461B2 (en) 2012-04-10 2015-09-15 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the ALAS1 gene
ES2728782T3 (es) * 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US10330674B2 (en) 2015-01-13 2019-06-25 Massachusetts Institute Of Technology Pumilio domain-based modular protein architecture for RNA binding
EP3475424A1 (en) * 2016-06-22 2019-05-01 ProQR Therapeutics II B.V. Single-stranded rna-editing oligonucleotides
EP3487998B1 (en) * 2016-07-19 2023-07-12 Brandeis University Compositions and methods for identifying rna binding polypeptide targets
WO2018049075A1 (en) * 2016-09-07 2018-03-15 Flagship Pioneering, Inc. Methods and compositions for modulating gene expression
AU2017327384B2 (en) * 2016-09-13 2021-05-20 The Jackson Laboratory Targeted enhanced DNA demethylation
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
WO2018160908A1 (en) * 2017-03-03 2018-09-07 Flagship Pioneering, Inc. Methods and systems for modifying dna

Similar Documents

Publication Publication Date Title
EP4261284A1 (en) Stable target-editing guide rna to which chemically modified nucleic acid is introduced
JP7478923B2 (ja) シュードウリジン化のための核酸分子
CN107406852B (zh) 用于莱伯氏先天性黑蒙的寡核苷酸疗法
EP3348636B1 (en) Method for modifying genome sequence that specifically converts nucleobase of targeted dna sequence, and molecular complex used in said method
AU2025203312A1 (en) Viral and non-viral nanoplasmid vectors with improved production
JP2022034059A (ja) Pd-l1発現低減用のオリゴヌクレオチド
ES2757623T3 (es) Proteínas de unión a ADN inducibles y herramientas de perturbación genómica y aplicaciones de las mismas
KR20210029772A (ko) 유전자 편집을 위한 변형된 가이드 rna
CA2964979A1 (en) Compounds and methods for the modulation of proteins
US20060058253A1 (en) Methods to reprogram splice site selection in pre-messenger rnas
JP7384033B2 (ja) 一本鎖オリゴヌクレオチド
CN101448945A (zh) 用于诱导外显子跳跃的手段和方法
JP2015523854A5 (cg-RX-API-DMAC10.html)
US20210340568A1 (en) Regulated gene editing system
WO2022248879A1 (en) Composition and method for adar-mediated rna editing
JP2024519733A5 (cg-RX-API-DMAC10.html)
EP4671372A2 (en) Translation-enhancing nucleic acid compounds: Upward regulation 1 coupled with ASO (ACT-UP1) and their uses
KR20240040112A (ko) 방법
WO2022261115A1 (en) Peptide nucleic acids for spatiotemporal control of crispr-cas binding
JP2025094072A (ja) B型肝炎ウイルス感染を処置するためのcops3阻害剤の使用
Watts Nucleic acid therapeutics
CN111712508A (zh) 核酸单元及其聚合核酸与应用
Chaix et al. 3′-3′-linked oligonucleotides: Synthesis and stability studies
WO2026094932A1 (ja) 標的ヌクレオチド配列の改変のための二本鎖ヌクレオチド複合体
EP4698645A1 (en) Nucleic acid molecules for pseudouridylation